Crossmark

Cluster headache treatment — RCTs versus real-world evidence

Crossref DOI link: https://doi.org/10.1038/nrneurol.2016.134

Published Online: 2016-09-12

Published Print: 2016-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Martelletti, Paolo

Curto, Martina
License Information

Text and Data Mining valid from 2016-09-12
More Information

Article History

First Online: 12 September 2016

Competing interests

: The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in conflict with the subject matter discussed in the manuscript. In the past 3 years, P.M. has received research grants and educational funds from Allergan, Pfizer and ACRAF, paid directly to Sapienza University. P.M. has also received personal honoraria for advisory boards, travel and lectures from Allergan, Mylan, Teva and Bayer. M.C. declares no competing interests.